Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Sales (2020 - 2025)

Historic Return on Sales for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 0.42%.

  • Biodesix's Return on Sales rose 1700.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.6% for FY2024, which is 4400.0% up from last year.
  • As of Q3 2025, Biodesix's Return on Sales stood at 0.42%, which was up 1700.0% from 0.58% recorded in Q2 2025.
  • Biodesix's 5-year Return on Sales high stood at 0.22% for Q1 2021, and its period low was 2.38% during Q1 2022.
  • In the last 5 years, Biodesix's Return on Sales had a median value of 0.91% in 2024 and averaged 1.07%.
  • In the last 5 years, Biodesix's Return on Sales soared by 17200bps in 2021 and then crashed by -21700bps in 2022.
  • Quarter analysis of 5 years shows Biodesix's Return on Sales stood at 1.82% in 2021, then increased by 6bps to 1.71% in 2022, then skyrocketed by 63bps to 0.63% in 2023, then skyrocketed by 34bps to 0.41% in 2024, then dropped by -2bps to 0.42% in 2025.
  • Its Return on Sales was 0.42% in Q3 2025, compared to 0.58% in Q2 2025 and 0.6% in Q1 2025.